This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
28 Sep 2021

POLPHARMA API TECHNOLOGY EXPANSION & STRATEGIC DIRECTION

POLPHARMA API TECHNOLOGY EXPANSION

Recent investments in Polpharma API’ capabilities will support a strategic move into complex API development and manufacturing for CDMO partners and generics companies worldwide, empowering the global supply chain. Learn how Polpharma API enters into a strategic transformation process that aims to invest in new capabilities and technologies like high containment or cryogenic to be fully implemented by 2026. However, our production capacity will increase significantly already from mid-2023! 

Recent investments in Polpharma API’ capabilities will support a strategic move into complex API development and manufacturing for CDMO partners and generics companies worldwide

If you would like to meet our representatives and learn more, please contact us today: [email protected]; [email protected]

Mentioned Companies
Polpharma SA
View company profile